Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells

Class:IdLiteratureReference:2011956
_displayNameThe FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells
_timestamp2011-11-22 14:54:23
author[Person:2011706] Roidl, A
[Person:1614067] Foo, P
[Person:1614266] Wong, W
[Person:1614257] Mann, C
[Person:2011506] Bechtold, S
[Person:2011509] Berger, HJ
[Person:1614180] Streit, S
[Person:1614156] Ruhe, JE
[Person:1614085] Hart, S
[Person:179893] Ullrich, A
[Person:1614090] Ho, HK
created[InstanceEdit:2011954] Rothfels, K, 2011-11-22
journalOncogene
pages1543-52
pubMedIdentifier19946327
titleThe FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells
volume29
year2010
(literatureReference)[Complex:2011955] FGFR4 Y367C mutant dimer [plasma membrane] [Homo sapiens]
[Complex:2011990] Activated FGFR4 Y367C mutant [plasma membrane] [Homo sapiens]
[Pathway:1839128] FGFR4 mutant receptor activation [Homo sapiens]
[Reaction:2012086] Constitutive dimerization of FGFR4 Y367C mutant [Homo sapiens]
[Reaction:2012087] Autocatalytic phosphorylation of FGFR4 Y367C mutant [Homo sapiens]
[Reaction:5655241] Activated FGFR2 mutants:p-FRS2:GRB2:SOS1 activates RAS nucleotide exchange [Homo sapiens]
[Reaction:5655277] Activated FGFR3 point, translocation and fusion mutants:p-FRS2:GRB2:SOS1 activates RAS nucleotide exchange [Homo sapiens]
[Pathway:5655291] Signaling by FGFR4 in disease [Homo sapiens]
[Reaction:5655326] Activated FGFR1 mutants:p-FRS2:GRB2:SOS1 activates RAS nucleotide exchange [Homo sapiens]
[Reaction:5655347] Activated FGFR4 mutants:p-FRS2:GRB2:SOS1 activates RAS nucleotide exchange [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells (2011956)